Chemoinformaics analysis of Methyl propyl trisulfide
| Molecular Weight | 154.325 | nRot | 4 |
| Heavy Atom Molecular Weight | 144.245 | nRig | 0 |
| Exact Molecular Weight | 153.994 | nRing | 0 |
| Solubility: LogS | -4.394 | nHRing | 0 |
| Solubility: LogP | 2.109 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 17 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 22.0479 |
| nHD | 0 | BPOL | 12.4921 |
| QED | 0.451 |
| Synth | 3.621 |
| Natural Product Likeliness | 1.703 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.006 |
| HIA | 0.006 |
| CACO-2 | -4.389 |
| MDCK | 0.0000262 |
| BBB | 0.753 |
| PPB | 0.500546 |
| VDSS | 1.163 |
| FU | 0.327069 |
| CYP1A2-inh | 0.921 |
| CYP1A2-sub | 0.935 |
| CYP2c19-inh | 0.958 |
| CYP2c19-sub | 0.891 |
| CYP2c9-inh | 0.757 |
| CYP2c9-sub | 0.815 |
| CYP2d6-inh | 0.052 |
| CYP2d6-sub | 0.796 |
| CYP3a4-inh | 0.015 |
| CYP3a4-sub | 0.246 |
| CL | 11.719 |
| T12 | 0.222 |
| hERG | 0.191 |
| Ames | 0.588 |
| ROA | 0.898 |
| SkinSen | 0.946 |
| Carcinogencity | 0.323 |
| EI | 0.996 |
| Respiratory | 0.983 |
| NR-Aromatase | 0.027 |
| Antiviral | No |
| Prediction | 0.953815 |